Agios Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Welcome, everyone, to the 40th Annual J.P. Morgan Healthcare Conference. My name is Anupam Rama, I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Caleb Smith, [Malcolm Kuno] and Priyanka Grover from the team. Our next presenting company is Agios, and presenting on behalf of the company, we have CEO, Jackie Fouse. I want to remind all the listeners of this session that there is an ask a question feature in the portal. And if you'd like to put a question in the portal, I would be happy to ask on your behalf.
With that, Jackie, take it away.
Good morning, everybody. Thanks, Anupam. Great to be here with you this morning, and thanks for attending our presentation. I am sharing slides on the screen, and so I'm going to drive those slides. And for those of you who may want to follow along on your own, you can do that as well and you can see my slides on the screen and follow along with those.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |